Pioneering PACE trial begins at Torbay Hospital
After lots of hard work, planning and preparation, Torbay and South Devon NHS Foundation Trust’s Radiotherapy department were delighted to treat their first patient using stereotactic ablative radiotherapy (SABR) as part of the pioneering PACE trial.
It was announced earlier this year that the Trust would be the first in the South West to open the PACE trial to treat prostate cancer patients.
The PACE trial involves the use of a new technique called SABR which uses advanced imaging technologies with sophisticated computer planning to safely deliver precisely targeted radiotherapy using fewer higher doses of radiation. This means patients attend hospital for as little as five visits as opposed to many more over several weeks.
It has taken a lot of hard work by teams in Radiotherapy, Medical Physics and Oncology Research and Development departments, as well as many other staff across the organisation who provided support which made this possible.
A special thank you must also go to the patients who are taking part, including Barry Jarvis who is the first patient to be treated as part of the trial at Torbay Hospital.
Barry, on becoming the first patient to be treated using the SABR technique at the Trust, said: “I feel very privileged to be involved with the PACE trial and have appreciated fewer trips to the hospital. I feel that it is important to participate in research to help other patients in the future.
“The staff in the Oncology department have been fantastic. They have been helpful and reassuring at all times.”
The treatment is seen as an excellent alternative to surgery, while facilitating treatment closer to home and avoiding the need for patients to travel as frequently. The treatment will also increase the Trust’s capacity to treat cancer patients while allowing vulnerable patients to reduce the number of times they visit hospital.
The development of stereotactic radiotherapy has been enabled by the Trust’s investment in modern linear accelerators to deliver this most sophisticated form of radiotherapy.
The Trust is also keen to recognise the support and achievements of Peter Hosking and the Torbay Prostate Support Association (TPSA). Peter was the founding member of the TPSA in 1999 and was named as a Medallist of the Order of the British Empire in the New Year’s Honours List in recognition of this work.
The TPSA has raised substantial funding that over the years has directly helped and supported patients, and improved prostate cancer diagnosis and treatment at Torbay Hospital.